About: Psyence Biomedical Ltd., an integrated biopharmaceutical company, focuses on the development of botanical psilocybin-based psychedelic medicines. Its lead product candidate is NPX-5, a botanical drug candidate that is in Phase IIb clinical study for the treatment of adjustment disorder in patients with cancer in a palliative care setting. The company is based in Toronto, Canada. Psyence Biomedical Ltd. is a subsidiary of Psyence Group Inc.
Sector: Healthcare
Industry: Biotechnology
Latest price: $3.18 (-3.34%)
PBM NASDAQ Psyence Biomedical Ltd. Common Shares
Psyence Biomedical Ltd. Common Shares share price
Atividade de preço de PBM
Último preço
$ 3,180
Variação (24h)
-0,11 USD (3,34%)
Volume
16.98K
Volume (média 4 sem.)
-
Abertura
$ 3,44
Variação do dia
$ 3,10 - $ 3,44
Fechamento anterior
$ 3,29
Último negócio
04 Nov, 9:00 pm GMT+0
Atrasado
04 Nov, 9:00 pm GMT+0
PBM price performance
Atrasado
04 Nov, 9:00 pm GMT+0
PBM details
quote.marketSignals